Issue Information

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2026)

Issue Information
Published: (2025)

Issue Information
Published: (2026)

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2026)

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2026)

Issue Information
Published: (2025)

Bioequivalence Assessment of Two Dapoxetine Hydrochloride Formulations in Healthy Chinese Males Under Fasted and Fed Conditions
by: Yumin Li, et al.
Published: (2024)

Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function
by: Mason W. Freeman, et al.
Published: (2024)

Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers
by: Shengling Hu, et al.
Published: (2024)

Pharmacokinetics and Bioequivalence of Vardenafil Hydrochloride in Healthy Chinese Volunteers
by: Sheng He, et al.
Published: (2024)

Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women
by: Mong‐Jen Chen, et al.
Published: (2024)

Pharmacokinetic and Bioequivalence Evaluation of Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate, and Aspirin Tablets in Healthy Chinese Subjects in the Fasting and Postprandial Conditions
by: Fang Yao, et al.
Published: (2024)

Evaluation of Acarbose Bioequivalence in Healthy Chinese Populations Using Novel Pharmacodynamic End Points
by: Linling Que, et al.
Published: (2024)

Effect of a High‐Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant Tablet
by: Ramesh R. Boinpally, et al.
Published: (2024)

Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants
by: Hari V. Kalluri, et al.
Published: (2024)

Pharmacokinetics and Bioequivalence of a Generic Ticagrelor 90‐mg Formulation Versus the Innovator Product in Healthy White Subjects Under Fasting Conditions
by: Simona Rizea‐Savu, et al.
Published: (2024)

Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
by: Junyu Xu, et al.
Published: (2024)

Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study
by: Chenning Zhang, et al.
Published: (2024)

A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk
by: Chenna Keshava Reddy Sannala, et al.
Published: (2024)

A Drug‐Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2‐ and MATE1‐Mediated Transport of Metformin in Healthy Participants
by: Rajinder Bhardwaj, et al.
Published: (2024)

Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine
by: Hyung Soon Lim, et al.
Published: (2024)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants
by: Assem el Baghdady, et al.
Published: (2024)

Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults
by: Mohamed‐Eslam F Mohamed, et al.
Published: (2024)

Effect of Carbamazepine on the Pharmacokinetics of Erdafitinib in Healthy Participants
by: Pharavee Jaiprasart, et al.
Published: (2024)

Effect of Erdafitinib on the Pharmacokinetics of Midazolam and Metformin in Patients With Advanced Solid Tumors Harboring FGFR Gene Alterations
by: Wei Zhu, et al.
Published: (2024)